. Depressive symptoms are associated with soluble P-selectin reactivity to acute exercise in heart failure. Depressive symptoms are associated with soluble P-selectin reactivity to acute exercise in heart failure Abstract BACKGROUND: To determine the effects of depressive symptom severity on the circulating soluble adhesion molecule response to an acute exercise challenge in patients with heart failure (HF) compared with control subjects. METHODS: Thirty-eight male HF patients and 19 male control subjects (mean age +/-SEM: 55.5 +/-1.9) completed the Beck Depression Inventory (BDI) before undergoing a moderate 20-minute bicycle exercise at approximately 65% to 70% VO(2peak). Plasma levels of the soluble adhesion molecules P-selectin (sP-selectin) (sCD62P) and soluble intercellular adhesion molecule-1 (sICAM-1) were determined immediately before and after and 10 minutes after exercise. RESULTS: Higher BDI scores moderated greater increases in sP-selectin levels in response to exercise over time in HF patients as compared with control subjects [F(1.8/84.5) = 3.25, p = .05]. Post hoc testing revealed that in HF patients, but not in control subjects, higher BDI scores were significantly associated with greater increases in sP-selectin levels over time in response to exercise [BDI by exercise interaction: F(1.6/49.6) = 5.67, p = .010]. Also, in HF patients, but not in control subjects, higher BDI scores were associated with higher sP-selectin levels at pre-exercise and postexercise time points [main effect BDI: F(1/31) = 4.86, p = .035]. CONCLUSIONS: Our findings suggest that in male HF patients with increasing depressive symptom severity, levels of the adhesion molecule sP-selectin are higher before and after exercise and have greater increases in response to exercise. This could have implications for acute coronary syndromes associated with exercise and thereby may impact mortality.
BDI scores were significantly associated with greater increases in sP-selectin levels over time in response to exercise (BDI-by-exercise interaction: F(1.6/49.6) = 5.67, p = .010, η p 2 = .16).
Also, in HF patients, but not in controls, higher BDI scores were associated with higher sPselectin levels at pre and post-exercise time points (main effect BDI: F(1/31) = 4.86, p= .035, η p 2 = .14). Conclusions: Our findings suggest that in male HF patients with increasing depressive symptom severity, levels of the adhesion molecule sP-selectin are higher before and after exercise and have greater increases in response to exercise. This could have implications for acute coronary syndromes associated with exercise and thereby may impact mortality.
INTRODUCTION
Heart failure (HF) is an increasingly prevalent, chronic, progressive, and incurable medical condition that is a major cause of morbidity and mortality (1) (2) (3) . Although traditional medical risk factors in HF have been identified (4, 5) recent reviews suggest a role for depressive symptoms in the development and progression of HF (6, 7) . Depressive symptomatology varies between 51% in hospitalized HF patients and 69% in recently discharged HF patients (7) . Prospective studies indicate that higher levels of depressive symptoms as measured by the Beck Depression Inventory (BDI) in HF patients are independently associated with higher mortality within 3 years (7-9). However, little is known about pathophysiologic mechanisms underlying the increase in adverse outcomes in HF patients with depressive symptoms.
Physical activity may play an important role in the sudden onset of adverse events such as acute coronary syndromes (ACS). Physical exertion occurring within 1-2 hours of onset of symptoms has been identified as a potent trigger of acute myocardial infarction (MI) in patients with coronary artery disease (CAD) (10) (11) (12) . The underlying mechanisms, however, are still unclear. Recent studies suggest that adhesion molecules might be involved in mediating exercise-induced ACS triggering in vulnerable persons. In CAD patients Kop et al. found that treadmill exercise provoked significant immediate responses in the soluble intercellular adhesion molecule-1 (sICAM-1), a membrane-bound adhesion molecule expressed on endothelial cells and leukocytes (13, 14) . Moreover, in HF patients exercise induced profound increases in platelet activation markers such as soluble P-selectin (sPselectin), an adhesion molecule expressed on platelets and endothelial cells (15) . Both, ICAM-1 and P-selectin are clinically important because they support increased adhesion and infiltration of leukocytes and platelets, in the myocardium in HF patients (14, [16] [17] [18] [19] .
Particularly soluble P-selectin which is elevated in HF patients (20) seems to be an independent significant predictor of cardiovascular events in HF patients (21) . Exercise-3 induced elevations in either or both of these adhesion molecules may therefore be important in the disease course of HF.
Although sympathoadrenal hyperactivity and reactivity to mental and physical challenges have been suggested to be involved in pathophysiologic mechanisms linking depression and increased mortality in HF, the role of adhesion molecules and other inflammatory measures has received little attention (22, 23) . Therefore, the objective of the present study was to investigate whether depressive symptoms as assessed by the BDI are associated with exercise-induced changes in adhesion molecule levels in patients with HF and healthy controls. Plasma levels of sP-selectin and s-ICAM-1 were measured immediately before and after, and 10 min after a moderate exercise task. We hypothesized that higher BDI levels would be associated with greater adhesion molecule increases following exercise in HF patients as compared to controls.
METHODS

Study participants
The study sample consisted of 38 male patients diagnosed with HF and 19 male individuals with no cardiovascular pathology except for elevated blood pressure as a control group. Patients were recruited from the San Diego Veterans Affairs Medical Center and the University of California, San Diego Medical Center Heart Failure Program as part of a larger study on the effects of depression on cellular adhesion and inflammation. We recruited the control non-HF individuals from the local community via various advertisements (e.g., newspapers, flyers, brochures, and websites) and word of mouth referrals.
Inclusion criteria for all study participants included age between 30-85 years, hypertension < 180/110 mm Hg, and men of all ethnicities and races. Inclusion criteria for HF patients included NYHA classes II-IV, symptoms of HF for at least 3 months which have been optimally treated with beta-blockers, diuretics and ACE inhibitors, and systolic dysfunction defined by an ejection fraction ≤ 45% or diastolic dysfunction,. Left ventricular ejection fraction (LVEF) was assessed by echocardiography as part of the patient's routine medical evaluation. To assess functional capacity, we used the six-minute walk-test (24) .
Exclusion criteria included recent myocardial infarction (1 month), recent stroke or significant cerebral neurological impairment, severe chronic obstructive pulmonary disease, inability to exercise and psychiatric illness other than depression and comorbid anxiety.
Subjects were instructed to abstain from taking aspirin for 24 hours prior to the testing session.
The protocol was approved by the UCSD Institutional Review Board, and participants gave written informed consent. The study was carried out in accordance with the Declaration of Helsinki principles.
Study protocol
Depressive symptom severity 
Exercise testing
The exercise testing sessions commenced at approximately 11:30 am and lasted for 1.5 hours. Participants abstained from food and drink (other than water) for two hours before the experiment, and from physical exercise, alcohol and caffeinated beverages starting the evening before the test day.
Subjects performed a mild graded exercise task on a stationary bicycle (Viasprint 150p, Viasys, Yorba Linda, CA). Following a 5-10-min quiet rest, resting BP was taken using an automated BP monitor (Dinamap Compact BP ® monitor, Critikon, Tempa, FL) and venous blood was taken via an intravenous catheter that was placed in the antecubital vein 3hours prior. Subjects began peddling on the bicycle and continued at the pace of their choice (e.g., 60bpm). The bicycle protocol consisted of a 5 minute warm-up, 10 min steady state, and 2 min cool-down period. In order to apply the similar exercise intensity in relative to existing fitness levels for all participants, Borg's ratings of perceived exertion (RPE) scale (28) was used; the resistance (watts) of the bicycle was gradually increased during the warmup period to reach the rating of 12-13 ("somewhat hard") and this perceived exertion level was maintained for the 10-min steady state exercise by adjusting the resistance and speed of cycling. Based on our previous experience (29, 30) , RPE of 12-13 consistently corresponds to 65-70% of VO 2peak regardless of fitness levels. Blood pressure, heart rate, and oxygen saturation levels (via a finger probe) were monitored throughout the bicycle exercise every 2
minutes. Blood samples were obtained prior to, immediately following, and 10 minutes postexercise. Exercise was terminated if a subject expressed discomfort, excessive muscle fatigue, chest pain, shortness of breath, or if blood pressure exceeded 220/100 mmHg or dropped below resting levels.
Biochemical analyses
Blood was drawn into EDTA-coated vacutainer tubes (BD Biosciences, San Jose, CA, USA) for soluble adhesion molecules and catecholamines. Blood samples were centrifuged for 10min at 3,000g and 4°C and plasma was stored at -80°C until analysis.
Circulating levels of soluble sP-selectin and sICAM-1 were determined following previous methods using enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Mpls., MN) (31, 32) . The precision and sensitivity performance values were: sICAM-1, intra-assay CV is 4.6%, inter-assay CV is 6.6, sensitivity is <0.35 ng/ml; sP-selectin intraassay CV is 5.1%, inter-assay CV is 8.8, sensitivity is <0.5 ng/ml.
To minimize intra-assay error variance, all samples from an individual subject were analyzed in the same run.
Statistical Analyses
All calculations were performed using SPSS Inc. (version 11.0.1) software packages (SPSS, Chicago, IL). Data are presented as mean ± SEM. Results were considered statistically significant at the p≤ .05 level and all tests were two-tailed. In both groups, normal distribution of data was verified prior to statistical analyses using the KolmogorovSmirnov test. In case of missing data, cases were excluded listwise. We calculated mean arterial pressure (MAP) from resting BP readings (1/3 systolic BP + 2/3 diastolic BP) and body mass index (BMI) was calculated by the formula: weight in kg / (height in m) 2 .
Power analyses suggest that a total sample size of N = 44 is needed to detect an interaction effect between depressive symptom severity (as measured by BDI) and adhesion To test for group differences in sociodemographic and medical characteristics we computed univariate analyses of variance (ANOVA, General linear models with repeated measures were calculated to test whether exercise induced significant changes over time in soluble adhesion molecule levels in HF patients and controls with subject group as independent and repeated measures of adhesion molecule levels as dependent variables (Table 2) .
Associations with depressive symptom severity. For independent associations between depressive symptom severity and adhesion molecules we applied the following procedure. To address associations at rest, we calculated linear regression analyses with pre-exercise measures of adhesion molecules as dependent variables and BDI scores as continuous independent variable while controlling for the group variable (HF vs. controls). To address associations between depressive symptom severity and adhesion molecule changes over time in response to exercise we calculated general linear models with repeated measures of adhesion molecules as dependent variables. We entered BDI score as independent continuous variable while controlling for the group variable and pre-exercise adhesion molecule levels.
To address whether associations between depressive symptom severity and adhesion molecules differ between HF patients and controls, we calculated moderator analyses as described by Baron & Kenny both, for resting adhesion molecule levels and for repeated adhesion molecule measures. We recalculated the above described regression analyses and general linear models and additionally entered the interaction between group and BDI score as independent variable (34, 35) . In case of significant moderator effects of depressive symptoms we recalculated the analyses of the respective parameter separate for each group as post-hoc test. In HF patients, we additionally controlled for LVEF and NYHA class to test whether the observed associations are mediated by HF severity, and for current diabetes mellitus.
In calculations on associations with depressive symptom severity, all included parameters were Z-transformed prior to analyses rendering a mean of 0 and a standard deviation of 1 to allow computation of interaction terms.
To graphically illustrate our continuously calculated significant findings we categorized the study groups based on their BDI score into four groups of subjects with either high or low BDI score (HF-BDI-high (≥ 8, n=21), HF-BDI-low (< 8, n=17), controls-BDIhigh (≥ 8, n=14), controls-BDI-low (< 8, n=5), Figure 1 ). 
RESULTS
Sociodemographic and medical characteristics of the study groups
Reactivity of adhesion molecules to exercise
Depressive symptom severity and adhesion molecules
As aforementioned, we first tested whether depressive symptom severity is associated with adhesion molecules in both groups (i.e. independent of groups). Second, we investigated whether associations between depressive symptom severity and adhesion molecules differ between HF patients and controls by means of moderator analysis. Cardiovascular risk factors (age, BMI, MAP, and smoking) were controlled in all analyses.
At rest. Regression analyses revealed that independent of groups (HF vs. controls) BDI scores were not significantly associated with pre-exercise levels of sP-selectin (β=-.05, p=.76) or s-ICAM (β=-.07, p=.63) (Figure 1 ). There was no moderation effect of depressive symptom severity on group differences in pre-exercise adhesion molecule levels (p's>.23). 
Reactivity to exercise.
DISCUSSION
This is the first study to investigate whether in male HF patients and healthy controls, depressive symptoms are associated with exercise-induced increases in circulating levels of adhesion molecules expressed on endothelial cells and leukocytes (ICAM-1) as well as on endothelial cells and platelets (P-selectin). Our main finding was that in HF patients but not in controls higher depressive symptom scores were associated with higher sP-selectin increases in response to exercise over time peaking immediately after exercise cessation.
Moreover, higher levels of depressive symptoms were associated with higher sP-selectin levels at all time points in our HF patients but not in controls. These associations were of large effect sizes and independent of both cardiovascular risk factors, indicators of HF severity, and diabetes mellitus status. In other words, in HF patients with increasing depressive symptom severity, sP-selectin levels are not only on a generally higher level before and after exercise but also increased more strongly in reaction to a moderate bicycle exercise. Noteworthy, both BDI subscales (i.e. somatic symptoms and cognitive/affective symptoms) similarly contributed to the observed associations (see supplement 3). In contrast, there were no associations between depressive symptoms and s-ICAM-1 levels, either at rest nor in response to exercise.
Our findings indicate a diverging pattern between depressive symptoms and the two measured soluble adhesion molecules in HF patients suggesting a role for platelet activation.
sP-selectin but not s-ICAM-1 relates to platelet activation. P-selectin is constituitively expressed both in the α-granules of platelets and the Weibel-Palade bodies of endothelial cells, with a soluble form present in the plasma (36, 37) . It plays a crucial role in thrombus formation interconnecting inflammatory, thrombotic and coagulation activity (36) . More precisely, P-selectin translocates to the surface of activated platelets incorporated into a growing thrombus and supports recruitment of circulating leukocytes. It induces expression of tissue factor (TF) on monocytes and mediates binding of platelets to monocytes and neutrophils. As TF binds coagulation factor VII and activates coagulation factors IX and X, P-selectin-induced TF synthesis on monocytes seems to support and maintain the local activation of blood coagulation in the hours following monocyte recruitment (36) . Following expression on the platelet surface P-selectin is rapidly shed. This shedding from platelets is suggested to be the main source of the soluble form found in plasma following thrombotic events (38, 39) . However, although the P-selectin translocated on activated endothelial cells is recycled back into the cell, part of the soluble P-selectin found in plasma may be of endothelial origin (36, 40) . Noteworthy, markers of platelet activity other than sP-selectin have also been positively associated with HF and HF severity (41) . ICAM-1 is expressed by several cell types including leukocytes and endothelial cells (14), but to the best of our knowledge not by platelets. In vitro studies using cultured endothelial cells established that sICAM-1 simply reflects ICAM-1 expression on these cells (42) . Thus, in HF patients depressive symptoms may be associated with higher platelet but not endothelial activity before and after as well as in reaction to exercise.
We observed strong associations between depressive symptoms and higher levels of the measured soluble adhesion molecules in HF patients but not in controls. Moreover, low LVEF (as an indicator of HF severity) was significantly associated with repeated sP-selectin levels. Thus, our results suggest that associations between depressive symptoms and higher sP-selectin levels following exercise seem to be specific to HF patients but not controls.
Noteworthy, depressive symptom severity was significantly lower in controls as compared to HF patients. Therefore, we can not completely rule out that in a non-HF control group with higher levels of depressive symptoms there might be associations with sP-selectin levels following exercise. Such reasoning is in line with the reported significant associations between BDI scores and repeated sP-selectin levels independent of groups (i.e. main effect of BDI and interaction BDI-by-exercise). However, it is possible that the latter associations became significant because of the strong associations within the HF group.
The finding on higher platelet activity following exercise in HF patients is in line with a recent study reporting increases in several platelet activation markers including sP-selectin in HF patients following exercise (15) . Noteworthy, this study used a maximum treadmill graded exercise inducing sP-selectin increases in all patients whereas we used a moderate exercise testing, inducing increases only in patients with higher levels of depressive symptoms. It is interesting that the depression effect we observed was evident in response to our moderate exercise challenge -one that was not challenging enough to induce a sPselectin increase in HF patients with little or no depression or controls but only in those HF patients with greater depressive symptoms.
Our findings may have clinical implications, since both platelet-derived and endothelial-derived P-selectin play important roles in different phases of atherosclerosis. In addition to its role in thrombus formation and coagulation, platelet-expressed P-selectin may affect later phases of atherosclerosis via the generation of circulating pro-inflammatory platelet-leukocyte aggregates. These aggregates seem to promote plaque progression and increased levels of these aggregates have been found in stable and acute coronary syndromes (43, 44) . Endothelial-derived P-selectin supports leukocyte tethering and rolling which is required for the firm adhesion/activation and transmigration of leukocytes, a critical step in the early phase of the atherosclerotic process (45) (46) (47) . Changes in platelet activity play an important role in patients with coronary artery disease (CAD) since thrombus formation has been shown to be the major cause of ACS in these patients (41, 48) . The precise role of increased platelet activation in patients with HF, however, is less apparent. It appears to be part of the shift towards a pro-inflammatory state that is characteristic of heart failure (41, 49, 50) . In this setting, increases in platelet activity would be expected to predispose patients to a thrombotic state. The resultant increase in pulmonary and systemic emboli and myocardial ischemia (particular in HF patients with underlying CAD) would adversely affect morbidity and mortality in this population. Given the atherogenic properties of sP-selectin and given that physical exertion is suggested to play an important role in the onset of ACS (10-12) our results might suggest a mechanism underlying the association between depressive symptom severity and heightened mortality in HF patients. HF patients with higher levels of depressive symptoms may be particularly susceptible to exercise-induced triggering of ACS because of heightened sP-selectin expression and thereby platetet activation in response to moderate exercise. In line with such reasoning, a recent study by Strike et al. similarly suggests a role for heightened platelet activity in mediating ACS triggering (51) . In that study, ACS survivors who had experienced emotional but not exercise-induced ACS triggering in the 2 hours before symptom onset showed elevated proportions of platelet-leukocyte, -monocyte, and -neutrophil aggregates in reaction to psychological stressors. As mentioned earlier, these aggregates can be promoted by sP-selectin. Also, although sP-selectin levels had returned to near resting levels within 10 minutes of exercise cessation, it is likely that the effects on platelet aggregate formation and subsequent platelet proinflammatory activity continue for at least 30 minutes (36, 51) . Given that a moderate exercise as used in our study might be comparable to the physical activity a patient may perform in daily life and given the known ACS triggering effect of physical exertion our findings might be of clinical importance.
The molecular mechanisms leading to higher sP-selectin responses to exercise with depressive symptom severity in HF remain to be investigated. Although epinephrine is known to activate platelet activity (37) and although norepinephrine has been suggested to mediate mental stress-induced increases in platelet P-selectin in depressive caregivers (52) our data indicate that the observed associations in our study were neither mediated nor moderated by catecholamine secretion (see supplement 1). This non-significant finding could relate to the fact that almost all of our patients were using beta-blockers. Although beyond the scope of the present study, a speculative explanation for the observed associations between sP-selectin reactivity to exercise and depressive symptom severity in our HF patients may relate to genetic differences as a functional polymorphism in the promoter region of the serotonin transporter gene (5HTTLPR) has been associated with platelet activation in depression. Other potential explanations include activation of pro-inflammatory mechanisms and metabolic dysregulation which are known to increase proclivity to platelet activation and thrombotic events (37, 41) .
Strengths and limitations of our study are discussed in supplement 3.
In conclusion, our findings suggest that with increasing depressive symptom severity, levels of the adhesion molecule sP-selectin are not only higher before and after exercise but also showed greater exercise-induced increases in male HF patients as compared to controls.
Future research would benefit from including more measures of platelet activity and address Values are means ± SEM; pre-exercise: immediately before exercise; post-exercise:
immediately after exercise cessation; recovery: 10 minutes after exercise cessation. 
